Overview

Study to Determine the Effect of Ketoconazole on the Pharmacokinetics of GDC-0980

Status:
Completed

Trial end date:
2011-12-01

Target enrollment:

Participant gender:

Summary

This will be an open-label, fixed-sequence, single-center, 2 period study. The study is designed to determine the effect of ketoconazole on the pharmacokinetics of GDC-0980.

Phase:

Phase 1

Details

Lead Sponsor:

Genentech, Inc.

Treatments:

Ketoconazole